{"slug":"aging-stack-intro","verification":{"valid":true,"entries":37,"head":"159636dae720d92c666531142316c4cb9b24883dba176fdbb60e369361f5234a"},"energy":{"passes":37,"tokens_in":16309,"tokens_out":2743,"tokens_total":19052,"cost_usd":0,"models":{"grok/grok-4.3":2,"grok-4.3":19,"system/audit-repair":9,"kimi/moonshot-v1-8k":2,"gemini/gemini-2.5-flash":1,"repair":1,"fill-slots":2,"owner":1},"head":"159636dae720d92c666531142316c4cb9b24883dba176fdbb60e369361f5234a"},"provenance":[{"ts":"2026-06-29T09:11:11.216Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"PEPTIDE DEFINITIONS (use for mechanism accuracy; no medical claims):\nBPC-157 — Body Protection Compound. Derived from gastric juice protein. Builds new blood vessels into damaged tissue locally. 100+ animal/cell studies (tendon, gut, muscle, bone, nerve).\nTB-500 — Synthetic Thymosin Beta-4. Moves repair cells to damage; clears stuck inflammation systemically. Production drops ~60% by age 60.\nARA-290 — Nerve repair peptide with human clinical trial data. Regrows damaged nerves; does not mask nerve pain.\nSemax — Brain peptide; upregulates BDNF for neuroprotection and cognitive recovery.\nSelank — Anxiolytic peptide; reduces anxiety without sedation or addiction (non-benzodiazepine pathway).\nPT-141 — Sexual function; brain-level arousal signaling (FDA-approved mechanism as Vyleesi).\nDSIP — Delta Sleep Inducing Peptide; natural deep sleep without Ambien-class hangover.\nKPV — Gut-specific anti-inflammatory; calms gut lining without systemic immune suppression.\nGHK-Cu — Tissue remodeling; builds collagen scaffolding. Production drops 60-80% with age.\nThymosin Alpha-1 — Immune modulation; supports immune function without suppressing it.\n\nWrite a data-first, evidence-graded article: Aging Repair Stack: BPC-157 + TB-500 + GHK-Cu\n\nAudience: everyone over 40. The problem: blood vessel density drops, TB-500 production drops 60%, GHK-Cu production drops 60-80% with age. Why the stack maps: BPC rebuilds blood vessels, TB restores repair signal, GHK-Cu rebuilds collagen scaffolding. Novelty: 7/10.\n\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate rat studies from human trials from user reports. No medical claims or treatment promises. Use repair-vs-suppression framing where relevant. register: source_ledger.","response":"{\n  \"slug\": \"aging-repair-stack-bpc-157-tb-500-ghk-cu\",\n  \"title\": \"Aging Repair Stack: BPC-157 + TB-500 + GHK-Cu\",\n  \"body\": \"## Age-Related Declines in Repair Mechanisms\\n\\nBlood vessel density declines with age. TB-500 (Thymosin Beta-4) production drops ~60% by age 60. GHK-Cu production drops 60-80% with age.\\n\\n## BPC-157 and Angiogenesis\\n\\nBPC-157 is derived from gastric juice protein. It builds new blood vessels into damaged tissue locally. This is supported by 100+ animal and cell studies on tendon, gut, muscle, bone, and nerve.\\n\\n## TB-500 and Repair Cell Mobilization\\n\\nTB-500 is synthetic Thymosin Beta-4. It moves repair cells to damage sites and clears stuck inflammation systemically.\\n\\n## GHK-Cu and Collagen Scaffolding\\n\\nGHK-Cu supports tissue remodeling by building collagen scaffolding.\\n\\n## Stack Mapping to Declines\\n\\nThe combination addresses vessel density loss via BPC-157 angiogenesis effects, reduced repair signaling via TB-500, and collagen decline via GHK-Cu. No human data exist on the combined stack for aging repair.\",\n  \"register\": \"source_ledger\",\n  \"claims\": [\n    {\n      \"id\": \"c1\",\n      \"text\": \"Blood vessel density drops with age.\",\n      \"section\": \"Age-Related Declines in Repair Mechanisms\",\n      \"tier\": \"mechanistic\",\n      \"source_ids\": [],\n      \"source_status\": \"unsourced\",\n      \"why_material\": \"Frames the problem the stack addresses.\"\n    },\n    {\n      \"id\": \"c2\",\n      \"text\": \"TB-500 production drops ~60% by age 60.\",\n      \"section\": \"Age-Related Declines in Repair Mechanisms\",\n      \"tier\": \"mechanistic\",\n      \"source_ids\": [],\n      \"source_status\": \"unsourced\",\n      \"why_material\": \"Frames the problem the stack addresses; no human data located.\"\n    },\n    {\n      \"id\": \"c3\",\n      \"text\": \"GHK-Cu production drops 60-80% with age.\",\n      \"section\": \"Age-Related Declines in Repair Mechanisms\",\n      \"tier\": \"human\",\n      \"source_ids\": [\"s1\"],\n      \"source_status\": \"sourced\",\n      \"why_material\": \"Direct plasma ","tokens_in":0,"tokens_out":0,"cost":0,"prev":"genesis","hash":"b90f4c22e2cce5c270ed7e4fb8630509f6925dc71e0cbb3431da36ebe2870c0e"},{"ts":"2026-06-29T11:01:13.483Z","model":"grok-4.3","action":"sources","prompt":"","input":"aging-stack-intro","response":"8 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"b90f4c22e2cce5c270ed7e4fb8630509f6925dc71e0cbb3431da36ebe2870c0e","hash":"efb8d16d42eca9e940d7c58852057300eb3bf6bb2acb735c29dd2a96fce5e025"},{"ts":"2026-06-29T11:01:33.357Z","model":"grok-4.3","action":"sources","prompt":"","input":"aging-stack-intro","response":"4 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"efb8d16d42eca9e940d7c58852057300eb3bf6bb2acb735c29dd2a96fce5e025","hash":"f783f43618acce4de9a7530d0fde328779db7a612c834cda37c6c3ff1ce68a54"},{"ts":"2026-06-29T11:02:09.329Z","model":"grok-4.3","action":"sources","prompt":"","input":"aging-stack-intro","response":"4 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"f783f43618acce4de9a7530d0fde328779db7a612c834cda37c6c3ff1ce68a54","hash":"7909eb1c1441725adb9047c7568fff9e2b5004a62d11e0efa66c6ecfc1f3ae35"},{"ts":"2026-06-29T11:03:18.805Z","model":"grok-4.3","action":"sources","prompt":"","input":"aging-stack-intro","response":"3 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"7909eb1c1441725adb9047c7568fff9e2b5004a62d11e0efa66c6ecfc1f3ae35","hash":"899452e2255f4116e2ec759977638f0c4227f8902691f73bec5d7be6db158431"},{"ts":"2026-06-29T11:03:43.230Z","model":"grok-4.3","action":"sources","prompt":"","input":"aging-stack-intro","response":"3 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"899452e2255f4116e2ec759977638f0c4227f8902691f73bec5d7be6db158431","hash":"6bab3e9d5a44cc9cdeda0694ecbad1745fc54dcad56b05a5fa203b9b0b785a6d"},{"ts":"2026-06-29T11:04:18.052Z","model":"grok-4.3","action":"sources","prompt":"","input":"aging-stack-intro","response":"1 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"6bab3e9d5a44cc9cdeda0694ecbad1745fc54dcad56b05a5fa203b9b0b785a6d","hash":"f4a4c2ad3781338427844e0486c885395b44b69208421cee9473620d25ea7d3c"},{"ts":"2026-06-29T12:48:45.098Z","model":"system/audit-repair","action":"repair","prompt":"","input":"aging-stack-intro","response":"{\"materialized\":0,\"before\":[\"missing constitution slots: what_it_is, what_is_known, what_is_unknown, limitations, disclaimer\"],\"after\":[\"missing constitution slots: what_it_is, what_is_known, what_is_unknown, limitations, disclaimer\"]}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"f4a4c2ad3781338427844e0486c885395b44b69208421cee9473620d25ea7d3c","hash":"38effe3c2e3e60b83385cfbdfae4d96d0a9a51be9265aaffc346b2b21ef2e265"},{"ts":"2026-06-29T12:48:45.733Z","model":"system/audit-repair","action":"claim","prompt":"","input":"aging-stack-intro c32","response":"Aging Repair Stack: BPC-157 + TB-500 + GHK-Cu is catalogued in this miscsubjects ledger as a tier-honest evidence graph (claims + hash-chained sources). This page summarizes what is claimed in the literature and online about the topic — not clinical recommendations.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"38effe3c2e3e60b83385cfbdfae4d96d0a9a51be9265aaffc346b2b21ef2e265","hash":"e4884687a7d75dbb1fa19d6ca1af7350b1f4918b4823fbed57272daad0715ff2"},{"ts":"2026-06-29T12:48:45.799Z","model":"system/audit-repair","action":"claim","prompt":"","input":"aging-stack-intro c33","response":"Per this ledger on Aging Repair Stack: BPC-157 + TB-500 + GHK-Cu: 15 scientific and 12 anecdotal sources are catalogued; 11 preclinical claim(s) summarize animal/cell literature in-catalogue.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"e4884687a7d75dbb1fa19d6ca1af7350b1f4918b4823fbed57272daad0715ff2","hash":"5684ee0cff86a3236d69aac380075ee90b83feb13a61efd42cbb285557004b76"},{"ts":"2026-06-29T12:48:45.961Z","model":"system/audit-repair","action":"claim","prompt":"","input":"aging-stack-intro c34","response":"Not established in this ledger: large randomized human trials for common marketed uses; long-term human safety beyond small pilots; condition-specific efficacy where only anecdotal or preclinical sources exist (explicit gaps remain in question graph).","tokens_in":0,"tokens_out":0,"cost":0,"prev":"5684ee0cff86a3236d69aac380075ee90b83feb13a61efd42cbb285557004b76","hash":"4ad8420850603d41369d3a0f0eb492cff830e01b19268b22825d39d6e2352e11"},{"ts":"2026-06-29T12:48:46.015Z","model":"system/audit-repair","action":"claim","prompt":"","input":"aging-stack-intro c35","response":"Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"4ad8420850603d41369d3a0f0eb492cff830e01b19268b22825d39d6e2352e11","hash":"627e4fbb9589b85022bd306a5ff0a13768a58fabeb1a5fb7ec9f4d2544e9162c"},{"ts":"2026-06-29T12:48:46.073Z","model":"system/audit-repair","action":"claim","prompt":"","input":"aging-stack-intro c36","response":"Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"627e4fbb9589b85022bd306a5ff0a13768a58fabeb1a5fb7ec9f4d2544e9162c","hash":"5d48feaa83fa306b2525c79e2be8c27eab83e1ab540da9ef7d3cff6a717b2e1e"},{"ts":"2026-06-29T12:48:46.720Z","model":"system/audit-repair","action":"repair","prompt":"","input":"aging-stack-intro","response":"{\"materialized\":0,\"before\":[],\"after\":[]}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"5d48feaa83fa306b2525c79e2be8c27eab83e1ab540da9ef7d3cff6a717b2e1e","hash":"e38448b8e1cc4681a1748302c70082f24496c7fdaa5d624c6323a16d3166eacc"},{"ts":"2026-06-29T13:15:21.796Z","model":"kimi/moonshot-v1-8k","action":"collaborate","prompt":"","input":"aging-stack-intro","response":"I am adding explicit gaps in knowledge and naming anecdotal claim sources as instructed, which are missing from the ledger.","tokens_in":2690,"tokens_out":465,"cost":0,"prev":"e38448b8e1cc4681a1748302c70082f24496c7fdaa5d624c6323a16d3166eacc","hash":"49817e879b5cf03aa5c16cc4c136ac2d9af13c6a50522161c16a0d6c5afa0ce4"},{"ts":"2026-06-29T13:16:05.788Z","model":"kimi/moonshot-v1-8k","action":"collaborate","prompt":"","input":"aging-stack-intro","response":"I am adding explicit gaps in knowledge regarding the aging repair stack and naming the sources of anecdotal claims as requested. I am not Grok because I am adding new claims that are not present in the original topology, filling in the gaps and providing more context to the existing claims.","tokens_in":2693,"tokens_out":418,"cost":0,"prev":"49817e879b5cf03aa5c16cc4c136ac2d9af13c6a50522161c16a0d6c5afa0ce4","hash":"268bada0c46a12e5dfe650ef058ce221c823172e206b525e492c7a737cb31110"},{"ts":"2026-06-29T13:21:19.523Z","model":"system/audit-repair","action":"repair","prompt":"","input":"aging-stack-intro","response":"{\"materialized\":0,\"before\":[],\"after\":[]}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"268bada0c46a12e5dfe650ef058ce221c823172e206b525e492c7a737cb31110","hash":"c642588df383c681bc557982c6f2bf33fb4f7e606f81fbeff7e66687cf6076bd"},{"ts":"2026-06-29T13:21:20.724Z","model":"system/audit-repair","action":"repair","prompt":"","input":"aging-stack-intro","response":"{\"materialized\":0,\"before\":[],\"after\":[]}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"c642588df383c681bc557982c6f2bf33fb4f7e606f81fbeff7e66687cf6076bd","hash":"ddaa034f59cca70f027e908fd5accdb93f886feb57bd20edc4b3334c353a80b1"},{"ts":"2026-06-29T14:42:55.488Z","model":"gemini/gemini-2.5-flash","action":"collaborate","prompt":"","input":"aging-stack-intro","response":"As Gemini, I've added three tier-honest claims to address explicit gaps in the ledger, focusing on 'what_is_unknown' and 'who_claims_what' slots. I've also challenged an overstrong, unsourced claim by referencing the ledger's own admission of lacking human data, enhancing the overall tier-honesty. I am not Grok.","tokens_in":2975,"tokens_out":614,"cost":0,"prev":"ddaa034f59cca70f027e908fd5accdb93f886feb57bd20edc4b3334c353a80b1","hash":"4af7233db4af9e7b33ca958ab16965789dd1c8d97949137e1fba9e5f81b7d0d5"},{"ts":"2026-06-29T14:43:48.880Z","model":"grok/grok-4.3","action":"synthesize_body","prompt":"","input":"aging-stack-intro","response":"## Regeneration vs degeneration — where this fits\n\nThe body breaks down tissue and builds it back at the same time. When breakdown runs ahead of repair, problems stay. Most drugs reduce pain or swelling signals but leave the damaged tissue. The stack of BPC-157, TB-500, and GHK-Cu is studied for repair steps: new blood vessels, repair cell movement, collagen building, and tissue remodeling. The ledger places these three compounds in that repair frame.\n\n## What it is\n\nBPC-157 is a 15-amino-acid chain first found in human gastric juice. TB-500 is a fragment of thymosin beta-4 that moves repair cells. GHK-Cu is a copper-binding tripeptide that drops with age. The stack combines these three. Sources list them together in reviews of wound-healing peptides for orthopaedic use (source s13, source s24).\n\n## How it works\n\nBPC-157 increases VEGF activity and supports new vessel growth into damaged areas in animal models (source s2, source s4). TB-500 moves repair cells and reduces stuck inflammation in preclinical studies. GHK-Cu drops from about 200 micrograms per liter in young adults to 80 micrograms per liter by age 60–80 and supports collagen scaffolding in dermal repair (source s1). Reviews note that the three act on overlapping paths: angiogenesis, extracellular matrix remodeling, and fibroblast activation (source s13, source s24).\n\n## Why it would work (logic chain)\n\nIf blood vessel density drops with age, then tissue gets less oxygen and nutrients. If GHK-Cu levels fall, then collagen scaffolding weakens. If repair cells stay stuck, then inflammation lingers. Adding compounds that increase local vessels, move repair cells, and rebuild matrix would, in principle, shift the balance toward regeneration. The ledger states that direct evidence for this full chain in human aging is missing.\n\n## Why people take it\n\nPeople take the stack for soft-tissue healing, joint pain, skin changes, and hair reports. Reddit users list knee pain, ACL recovery, TMJ pain, and skin thicknes","tokens_in":7951,"tokens_out":1246,"cost":0,"prev":"4af7233db4af9e7b33ca958ab16965789dd1c8d97949137e1fba9e5f81b7d0d5","hash":"1d55f1fb9374651595d07b9bd37ee2fea919f621b162e212452f10de666e6fb5"},{"ts":"2026-06-29T16:17:33.827Z","model":"grok-4.3","action":"sources","prompt":"","input":"aging-stack-intro","response":"4 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"1d55f1fb9374651595d07b9bd37ee2fea919f621b162e212452f10de666e6fb5","hash":"53ca47f317be4c82f2193a5361927e02ce2a56ed9f8f4b467e556f6cd6eda528"},{"ts":"2026-06-29T16:18:13.552Z","model":"grok-4.3","action":"sources","prompt":"","input":"aging-stack-intro","response":"2 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"53ca47f317be4c82f2193a5361927e02ce2a56ed9f8f4b467e556f6cd6eda528","hash":"ebbcd4a5f7cfa1f8e5d2b5423d68fea57697b38aaa81de3d3385b85392804494"},{"ts":"2026-06-29T16:18:54.720Z","model":"grok-4.3","action":"sources","prompt":"","input":"aging-stack-intro","response":"4 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"ebbcd4a5f7cfa1f8e5d2b5423d68fea57697b38aaa81de3d3385b85392804494","hash":"753f757095dae75021b7030e45fd3d521357a50fac428d5fec6e83dcba84ed7d"},{"ts":"2026-06-29T16:19:33.877Z","model":"grok-4.3","action":"sources","prompt":"","input":"aging-stack-intro","response":"5 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"753f757095dae75021b7030e45fd3d521357a50fac428d5fec6e83dcba84ed7d","hash":"0252f4d6b4d32301d597968f081dc2ca08fa9545224b2c48bd5e7da16192d756"},{"ts":"2026-06-29T16:19:48.677Z","model":"grok-4.3","action":"sources","prompt":"","input":"aging-stack-intro","response":"5 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"0252f4d6b4d32301d597968f081dc2ca08fa9545224b2c48bd5e7da16192d756","hash":"f74aa640200dc7cc8f67a6d855c78be45c3253d6f687cd25267c946595dd8b0d"},{"ts":"2026-06-29T18:20:25.805Z","model":"grok-4.3","action":"sources","prompt":"","input":"aging-stack-intro","response":"6 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"f74aa640200dc7cc8f67a6d855c78be45c3253d6f687cd25267c946595dd8b0d","hash":"84dab154306f010767087d13922e6ce462d89b7398c04d21ee9ee45f8dea5749"},{"ts":"2026-06-29T18:20:56.052Z","model":"grok-4.3","action":"sources","prompt":"","input":"aging-stack-intro","response":"6 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"84dab154306f010767087d13922e6ce462d89b7398c04d21ee9ee45f8dea5749","hash":"e026fe7e66dfe984bc2248d91938753ce1ef8e04da06d665f1f07b3c4f82caec"},{"ts":"2026-06-29T18:21:20.946Z","model":"grok-4.3","action":"sources","prompt":"","input":"aging-stack-intro","response":"2 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"e026fe7e66dfe984bc2248d91938753ce1ef8e04da06d665f1f07b3c4f82caec","hash":"f170ff84b82a1a5f749418c51997f1e1c0e3e74b206a944008a02c80b4ef38b1"},{"ts":"2026-06-29T18:22:28.074Z","model":"grok-4.3","action":"sources","prompt":"","input":"aging-stack-intro","response":"6 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"f170ff84b82a1a5f749418c51997f1e1c0e3e74b206a944008a02c80b4ef38b1","hash":"3865eeead1e323ada0687961d44c54b644780aad155939495bd4e7a5a76b9440"},{"ts":"2026-06-29T18:23:02.213Z","model":"grok-4.3","action":"sources","prompt":"","input":"aging-stack-intro","response":"6 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"3865eeead1e323ada0687961d44c54b644780aad155939495bd4e7a5a76b9440","hash":"2ff3bdc0f6a943bec5aabac10d68e385fa581bfbe58ba9749648aa74d50dd3f2"},{"ts":"2026-06-29T18:23:42.612Z","model":"grok-4.3","action":"sources","prompt":"","input":"aging-stack-intro","response":"2 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"2ff3bdc0f6a943bec5aabac10d68e385fa581bfbe58ba9749648aa74d50dd3f2","hash":"124a126064a79707e59b51cababea579d4dde0bae0c3348af6b7d6ca3a0e7512"},{"ts":"2026-06-29T18:24:30.013Z","model":"grok-4.3","action":"sources","prompt":"","input":"aging-stack-intro","response":"3 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"124a126064a79707e59b51cababea579d4dde0bae0c3348af6b7d6ca3a0e7512","hash":"23fe6e5b4a8206afa7317de61cb5f5f25384ad6622db5cd3ddba901e12f16e78"},{"ts":"2026-06-29T18:25:03.822Z","model":"grok-4.3","action":"sources","prompt":"","input":"aging-stack-intro","response":"5 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"23fe6e5b4a8206afa7317de61cb5f5f25384ad6622db5cd3ddba901e12f16e78","hash":"231215d3df47a35d3d4f9b8e91a3b0940a876487efa614b6271b4babf625d41f"},{"ts":"2026-06-29T19:54:04.255Z","model":"repair","action":"repair","prompt":"","input":"aging-stack-intro","response":"{\"materialized\":0,\"before\":[],\"after\":[],\"focus_stats\":{\"roles_assigned\":0,\"excluded_sources\":0,\"commercial_sources\":0,\"cut_claims\":0,\"core\":0,\"cycle\":55,\"adjacent\":28}}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"231215d3df47a35d3d4f9b8e91a3b0940a876487efa614b6271b4babf625d41f","hash":"88a1d3dc2f27dd460cdf2e37ca668a6fbd0beb2cc91503e1cc7d3322640e8e3c"},{"ts":"2026-06-29T21:05:04.208Z","model":"fill-slots","action":"claim","prompt":"","input":"aging-stack-intro c104","response":"Aging Repair Stack: BPC-157 + TB-500 + GHK-Cu is catalogued in this miscsubjects ledger as a tier-honest evidence graph (claims + hash-chained sources). This page summarizes what is claimed in the literature and online about the topic — not clinical recommendations.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"88a1d3dc2f27dd460cdf2e37ca668a6fbd0beb2cc91503e1cc7d3322640e8e3c","hash":"912742e3b3581c13f02f850660e08180310c13410e2b74b3b29382982d413da1"},{"ts":"2026-06-29T21:05:07.084Z","model":"fill-slots","action":"claim","prompt":"","input":"aging-stack-intro c105","response":"Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"912742e3b3581c13f02f850660e08180310c13410e2b74b3b29382982d413da1","hash":"642581a183bf03359442538113ac79ac310c0d171c07799e7a1260e7893f240e"},{"ts":"2026-07-17T02:37:59.920Z","model":"owner","action":"voxel_divide","prompt":"","input":"aging-stack-intro","response":"27 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"642581a183bf03359442538113ac79ac310c0d171c07799e7a1260e7893f240e","hash":"159636dae720d92c666531142316c4cb9b24883dba176fdbb60e369361f5234a"}]}